Le méthotrexate (59-05-2)
Methotrexate is a drug used for the treatment of cancer, also known as cytotoxic drugs. In order to reduce its cytotoxicity, it can be used in conjunction with calcium leucovorin. It is primarily used for the treatment of acute leukemia (acute lymphocytic leukemia), breast cancer, malignant mole and choriocarcinoma, head and neck cancer, bone cancer, leukemia, spinal cord meningeal infiltration, lung cancer, reproductive system cancer, liver cancer, refractory psoriasis
Salle disodique de méthotrexate (7413-34-5)
Methotrexate sodium is an inhibitor of trahydrofolate dehydrogenase, which is an anti-tumor antimetabolite and has immunosuppressive activity. Product Name: Methotrexate Disodium Salt CAS No.: 7413-34-5 Assay: 98% End Use: Methotrexate Molecular Formula: C20H20N8O5Na2 Molecular Weight: 498.41 Shelf Life: 2 Years Package: 25kg/drum
1,1,3-tribromoacétone (3475-39-6)
1,1,3-Tribromoacetone is used as intermediate of Methotrexate. Product Name: 1,1,3-Tribromoacetone CAS No.: 3475-39-6 Assay: 98% End Use: Methotrexate Molecular Formula: C3H3Br3O Molecular Weight: 294.77 Shelf Life: 2 Years Package: 25kg/drum
2,4-diamino-6- ((hydroxyméthyl) -pteridine hydrochlorure (73978-41-3)
2,4-diamino-6-(hydroxymethyl)-pteridine hydrochloride is used as intermediate of Methotrexate. Product Name: 2,4-diamino-6-(hydroxymethyl)-pteridine hydrochloride CAS No.: 73978-41-3 Assay: 98% End Use: Methotrexate Molecular Formula: C7H8N6O.HCl Molecular Weight: 228.64 Shelf Life: 2 Years Package: 25kg/drum
2,4-diamino-6- ((hydroxyméthyl) -pteridine (945-24-4)
2,4-diamino-6-(hydroxymethyl)-pteridine is used as intermediate of Methotrexate. Product Name: 2,4-diamino-6-(hydroxymethyl)-pteridine CAS No.: 945-24-4 Assay: 98% End Use: Methotrexate Molecular Formula: C7H8N6O Molecular Weight: 192.18 Shelf Life: 2 Years Package: 25kg/drum
6- ((chlorométhyl)pteridine-2,4-diamine monohydrochlorure (82778-08-3)
6-(chloromethyl)pteridine-2,4-diamine monohydrochloride is used as intermediate of Methotrexate. Product Name: 6-(chloromethyl)pteridine-2,4-diamine monohydrochloride CAS No.: 82778-08-3 Assay: 98% End Use: Methotrexate Molecular Formula: C7H8Cl2N6 Molecular Weight: 247.08 Shelf Life: 2 Years Package: 25kg/drum
Acide 4- ((méthylamino) benzoïque (10541-83-0)
4-(Methylamino)benzoic acid is used as intermediate of Methotrexate. Product Name: 4-(Methylamino)benzoic acid CAS No.: 10541-83-0 Assay: 98% End Use: Methotrexate Molecular Formula: C8H9NO2 Molecular Weight: 151.16 Shelf Life: 2 Years Package: 25kg/drum
Le sulfate de pyrimidinététramine (5392-28-9)
Pyrimidinetetramine sulfate is used as intermediate of Methotrexate. Product Name: Pyrimidinetetramine sulfate CAS No.: 5392-28-9 Assay: 98% End Use: Methotrexate Molecular Formula: C4H10N6O4S Molecular Weight: 238.22 Shelf Life: 2 Years Package: 25kg/drum
Le citrate de tofacitinib (540737-29-9) est un médicament à base de tofacitinib.
Tofacitinib citrate is a Janus kinase inhibitor, trade name Xeljanz, for the treatment of methotrexate inadequate response or intolerance to severe active rheumatoid arthritis (RA) in adult patients. Product Name: Tofacitinib Citrate CAS No.: 540737-29-9 Assay: 99% Specification: CP, EP, In-house, as required Molecular Formula: C22H28N6O8 Molecular Weight: 504.50 Shelf Life: 2 Years Package: 25kg/drum
